LLY · News · 20261031N
Revenue Performance and Mix
ELI LILLY & Co · 2026-10-31 · Importance 85 · Surprise 92 · No source text
Eli Lilly reported a 39% year-over-year revenue increase in the third quarter of 2026. Surging demand for Mounjaro and Zepbound drove the increase, although the digest provides no product-level revenue breakdown. Lilly raised its full-year revenue forecast after the third-quarter results, but the digest does not state the revised forecast amount.
Key facts
- Eli Lilly reported a 39% revenue increase after strong third-quarter results. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | positive | realized | +28.1% | Eli Lilly reported a 39% revenue increase after strong third-quarter results. |